Alli 60 mg. Capsules, Counterfeit Product

The FDA notified consumes and healthcare professionals about a counterfeit and dangerous version of Alli 60 mg capsules (120 count refill kit). The counterfeit version contains the controlled substance sibutramine which was substituted for orlistat, the active ingredient. GSK has determined that this version of Alli has been sold via the internet, there is no evidence that the product has been sold through other channels such as retail stores.

The differences between the two products can be described in the text and photos in the FDA’s news release. Consumers who believe they have received counterfeit Alli should contact the FDA’s Office of criminal Investigations by calling 800-551-3989 or by visiting the OCI website (http://www.fda.gov/OCI).

For more information please call 1-877 MESSALAW